BioStem Technologies, Inc. (OTCMKTS:BSEM) Short Interest Up 152.7% in April

BioStem Technologies, Inc. (OTCMKTS:BSEM) was the recipient of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 37,400 shares, a growth of 152.7% from the March 31st total of 14,800 shares. Based on an average trading volume of 68,700 shares, the days-to-cover ratio is presently 0.5 days.

BioStem Technologies Price Performance

BSEM traded down 0.30 during mid-day trading on Friday, reaching 9.11. 19,597 shares of the stock were exchanged, compared to its average volume of 29,291. The business has a 50 day moving average of 10.38. BioStem Technologies has a 1 year low of 1.20 and a 1 year high of 15.50.

BioStem Technologies (OTCMKTS:BSEM) last issued its quarterly earnings results on Monday, April 1st. The company reported -0.14 earnings per share for the quarter. The company had revenue of 11.44 million for the quarter, compared to the consensus estimate of 11.40 million. As a group, equities analysts anticipate that BioStem Technologies will post 3.14 EPS for the current year.

About BioStem Technologies

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.